Impact of corticosteroids in the immediate management of invasive meningococcal disease associated with hyperinvasive strains of the ST-11 clonal complex in children;Impact des corticoïdes dans la prise en charge immédiate des infections invasives à méningocoque liées aux souches hyper-invasives du complexe clonal ST-11chez l'enfant

Archives de Pediatrie

Volumn 21, Issue 3, 2014, Pages 258-264

  Madhi, F ^a,b,c   Levy, C ^a,c,d   Deghmane, A E ^e   Bechet S ^d   Cohen, R ^a,c,d   Taha, M K ^e  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c Groupe de Pathologie Infectieuse Pédiatrique GPIP   (France)

^d Association clinique et therapeutique infantile du Val de Marne ACTIV   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; COMA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; FULMINATING PURPURA; GENETIC VARIABILITY; HUMAN; INFECTION RATE; INVASIVE SPECIES; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MORTALITY; NEISSERIA MENINGITIDIS; NONHUMAN; PRESCRIPTION; SHOCK;

ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; NEISSERIA MENINGITIDIS; PROSPECTIVE STUDIES; PURPURA FULMINANS; TIME FACTORS;

EID: 84896723321     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/j.arcped.2013.12.024     Document Type: Article

References (22)

1. Brouwer M.C., McIntyre P., de Gans J., et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010, CD004405.
2. Esposito S., Semino M., Piccioli I., et al. Should corticosteroids be used in bacterial meningitis in children?. Eur J Paediatr Neurol 2013, 17:24-28.
3. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009, 301:2362-2375.
4. Grimprel E. Corticosteroids in children with bacterial meningitis: indications and administration. Med Mal Infect 2009, 39:539-546.
5. Tunkel A.R., Hartman B.J., Kaplan S.L., et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004, 39:1267-1284.
6. Chaudhuri A., Martinez-Martin P., Kennedy P.G., et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008, 15:649-659.
7. De Gaudio M., Chiappini E., Galli L., et al. Therapeutic management of bacterial meningitis in children: a systematic review and comparaison of published guidelines from a European perspective. J Chemother 2010, 22:226-237.
8. Visintin C., Mugglestone M.A., Fields E.J., et al. Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance. BMJ 2010, 340:c3209.
9. van Deuren M., van der Ven-Jongekrijg J., Bartelink A.K., et al. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995, 172:433-439.
10. Wright V., Hibberd M., Levin M., et al. Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes. Vaccine 2009, 27(Suppl. 2):B90-B102.
11. Sjostrom K., Spindler C., Ortqvist A., et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 2006, 42:451-459.
12. Trotter C.L., Fox A.J., Ramsay M.E., et al. Fatal outcome from meningococcal disease - an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J Med Microbiol 2002, 51:855-860.
13. Levy C., Taha M.K., Weil Olivier C., et al. Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children. Pediatr Infect Dis J 2010, 29:618-623.
14. Deghmane A.E., El Kafsi H., Giorgini D., et al. Late repression of NF-kB activity by invasive but not non-invasive meningococcal isolates is required to display apoptosis of epithelial cells. PLoS Pathog 2011, 7:e1002403.
15. Scarborough M., Gordon S.B., Whitty C.J., et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007, 357:2441-2450.
16. Nguyen T.H., Tran T.H., Thwaites G., et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007, 357:2431-2440.
17. Levy C., Taha M.K., Bingen E., et al. Méningites à méningocoques de l'enfant en France: résultats de l'observatoire ACTIV/GPIP. Arch Pediatr 2012, 19(Suppl. 2):49-54.
18. Parent du Châtelet I., Taha M.K., Lepoutre A., et al. Les infections invasives à meningocoques en France. BEH 2011, 45-46:477.
19. Riordan F.A., Marzouk O., Thomson A.P., et al. Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods. Eur J Pediatr 2002, 161:531-537.
20. Mongelluzzo J., Mohamad Z., Ten Have T.R., et al. Corticosteroids and mortality in children with bacterial meningitis. JAMA 2008, 299:2048-2055.
21. van de Beek D., Farrar J.J., de Gans J., et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010, 9:254-263.
22. Mogensen T.H., Berg R.S., Paludan S.R., et al. Mechanisms of dexamethasone-mediated inhibition of Toll-like receptor signaling induced by Neisseria meningitidis and Streptococcus pneumoniae. Infect Immun 2008, 76:189-197.